C22H17N3O5
Neat
403.40
Tadalafil EP Impurity G; 2520114-46-7; (12br)-6-(1, 3-benzodioxol-5-yl)-12-hydroxy-2-methyl-2, 3, 6, 12b-tetrahydropyrazino(1', 2':1, 5)pyrrolo(3, 4-b)quinoline-1, 4-dione; W48TH5ZE00; TADALAFIL IMPURITY G [EP IMPURITY]; Q27292279; (12bR)-6-(benzo[d][1, 3]dioxol-5-yl)-12-hydroxy-2-methyl-2, 3-dihydropyrazino[1', 2':1, 5]pyrrolo[3, 4-b]quinoline-1, 4(6H, 12bH)-dione; 6-(1, 3-BENZODIOXOL-5-YL)-12-HYDROXY-2-METHYL-2, 3, 6, 12B-TETRAHYDROPYRAZINO(1', 2':1, 5)PYRROLO(3, 4-B)QUINOLINE-1, 4-DIONE and (12BR)-
(11R)-17-(1, 3-benzodioxol-5-yl)-13-methyl-2, 13, 16-triazatetracyclo[8.7.0.03, 8.011, 16]heptadeca-1(10), 3, 5, 7-tetraene-9, 12 and 15-trione
InChI=1S/C22H17N3O5/c1-24-9-16(26)25-19(11-6-7-14-15(8-11)30-10-29-14)18-17(20(25)22(24)28)21(27)12-4-2-3-5-13(12)23-18/h2-8,19-20H,9-10H2,1H3,(H,23,27)/t19?,20-/m1/s1